At-A-Glance report 2014
|
|
- Annis Hardy
- 5 years ago
- Views:
Transcription
1 At-A-Glance report 14 Cystic Fibrosis in Europe Facts and Figures 14 The European Cystic Fibrosis Society Patient Registry (ECFSPR) is happy to present this report with key information about how cystic fibrosis (CF) affects people with CF and their families throughout Europe. The ECFSPR collects, measures and compares data of people with CF living in Europe and neighbouring countries who agree to be in the registry. The information is important to better understand CF, encourage new European standards of care and treatment, conduct research, and inform public health-planning. If you want to know more about the ECFSPR visit our website. For more in depth information see the full report here. vember 16 At-A-Glance report 14
2 Map of countries that contributed 14 data to the ECFSPR SW 626 IE 1218 PT 295 UK 1581 ES 1538 FR 6369 NL 1378 BE 1186 DK 488 CH 782 DE 53 CZ 599 IT 4981 AT 712 SI 97 LT 12 LV 38 SK 29 HU 557 RO 44 RS 169 MK 19 GR 517 MD 61 UA 147 RU 2122 IL ,582 registered patients in 26 countries number of patients on map MEDIAN AGE AT DIAGNOSIS 3.6 months Children Adults At-A-Glance report
3 Proportion children-adults The proportion children-adults varies between the countries. For some countries only a few individual centres sent data to the ECFSPR. Children and adults with CF in Europe Belgium is included only in this graph >=18 Years <18 Years Belgium Greece Hungary Italy Europe Genetics F58del mutation in Europe Other mutations F58del heterozygote F58del homozygote F58del is the most common CF-causing mutation in Europe People with CF have two CF-causing mutations, one inherited from the mother and one from the father Greece Hungary Italy Europe Homozygous: both mutations are the same. Heterozygous: the two mutations are different. 41 F58del homozygote 41 F58del heterozygote 18 Other mutations At-A-Glance report 14 3
4 FEV1 of predicted Lung function Median FEV1* Age Nutrition Children 9 LUNG FUNCTION Healthy peers People with CF Adults 68 LUNG FUNCTION FEV1 is a measure for lung function. It is the maximum amount of air that can be forcefully exhaled in the first second after taking a deep breath. FEV1 is a percentage of the average value for healthy people of the same age, gender and height, which is set at. In people with CF aged 45 and older there is a higher incidence of mutations causing milder forms of CF. This influences the lung function value for the people with CF in this age group represented. * In the 14 report we changed to a new way of calculating lung function; this means that, from now on, ECFSPR results can be easily compared with those of other CF registries around the world. BMI Median means that 5 of the values are above and 5 are below this value. BMI or body mass index is a measure for nutritional status: weight height 2 z-score indicates how far a value is from the average (mean) value of the reference population. Median BMI Z-score in children Median BMI in adults 1 23 BMI Z-Score Age Healthy children Children with CF BMI Age Adults with CF A z-score of means that the BMI is the same as the BMI of healthy children of the same gender and age. From the age of 8, children with CF have a lower average BMI than healthy children of a similar age. Healthy peers have values for BMI between 18 and 25. As people with CF get older BMI increases. In adults with CF aged 38 and older there is a higher incidence of mutations causing milder forms of CF. This influences the BMI for the adults in this age group represented. At-A-Glance report
5 Pancreatic enzymes 85 Pancreatic enzymes 85 of the people with CF use pancreatic enzyme supplements.* Enzymes released from the pancreas are vital for the digestion and absorption of fat and vitamins from food. In many people with CF the release of these enzymes is blocked and they must take supplements. of people with CF who use pancreatic enzyme supplements* Hungary * Missing values are not included nor are data from countries with a high of missing values. At-A-Glance report 14 5
6 Infection Pseudomonas 3 3 of the people with CF are chronically infected with the Pseudomonas aeruginosa bacteria in their lungs.* chronic Pseudomonas aeruginosa in children* chronic Pseudomonas aeruginosa in adults* * Missing values are not included nor are data from countries with a high of missing values. At-A-Glance report
7 Inhalation Treatment of people with CF who use hypertonic saline* of people with CF who use inhaled antibiotics* Hypertonic saline is prescribed to clear thick mucus from the lungs. Inhaled antibiotics are prescribed to treat CF specific bacteria, such as chronic Pseudomonas aeruginosa. * In these graphs the missing values are not included nor are data from countries with a high of missing values. Number Transplantation Number of people with CF living with a lung transplant Patients living with lung transplantation FEMALES 5.5 MALES 5.1 TOTAL 5.3 Patients living with liver transplantation FEMALES.4 MALES.6 TOTAL Males Females At-A-Glance report 14 7
8 At-A-Glance report 14
At-A-Glance report 2013
At-A-Glance report 213 Cystic Fibrosis in Europe Facts and Figures 213 The European Cystic Fibrosis Society Patient Registry (ECFSPR) is happy to present this report with key information about how cystic
More informationCystic Fibrosis. Parkland College. Monica Rahman Parkland College. Recommended Citation
Parkland College A with Honors Projects Honors Program 2013 Cystic Fibrosis Monica Rahman Parkland College Recommended Citation Rahman, Monica, "Cystic Fibrosis" (2013). A with Honors Projects. 98. http://spark.parkland.edu/ah/98
More informationPublic administration reforms and public sector performance in Central and Eastern Europe EU member states: in EU perspective
Public administration reforms and public sector performance in Central and Eastern Europe EU member states: in EU perspective Prof. Ing. Juraj Nemec, CSc. Masaryk University, Czech Republic, Size of government
More informationTransformational Treatments. PRESTON W. CAMPBELL, III, M.D. Executive Vice President for Medical Affairs
Transformational Treatments PRESTON W. CAMPBELL, III, M.D. Executive Vice President for Medical Affairs Symptom-based CF Therapies 45 Median Predicted Survival Age of US Patients with Cystic Fibrosis 41
More informationQuestions Q1. ) in the box next to your answer. (1) A FF B Ff C ff. D ff (ii) Explain why a person with cystic fibrosis (CF) may lose body mass.
Questions Q1. Cystic fibrosis (CF) is a recessive genetic disorder. The recessive allele is shown as f and the dominant allele as F. (a) (i) What is the genotype of a person with cystic fibrosis? Put a
More informationBMR Be l g i s c h Mu c o v i s c i d o s e Re g i s t e r
The Belgian CYSTIC FIBROSIS Registry Annual Report 2007 BMR Be l g i s c h Mu c o v i s c i d o s e Re g i s t e r RBM Registre Belge de la Mucoviscidose Scientific Institute of Public Health, Brussels
More informationOral Cystic Fibrosis Modulators
Oral Cystic Fibrosis Modulators Goals: To ensure appropriate drug use and limit to patient populations in which they have demonstrated to be effective and safe. To monitor for clinical response for appropriate
More informationTransmission, processing and publication of HBS 2015 data
EUROPEAN COMMISSION EUROSTAT Directorate F: Social statistics Unit F-4: Income and living conditions; Quality of life Doc. LC-ILC/194/17/EN estat.f.4 (2017) WORKING GROUP ON INCOME AND LIVING CONDITIONS
More informationPalliative nursing care of children and young people across Europe
Palliative nursing care of children and young people across Europe Results of a postal survey in August 2016 Updated in April 2017 (presented at the 29th PNAE-meeting in Naples/Italy on 28th April 2017)
More informationRespiratory Pharmacology: Treatment of Cystic Fibrosis
Respiratory Pharmacology: Treatment of Cystic Fibrosis Dr. Tillie-Louise Hackett Department of Anesthesiology, Pharmacology and Therapeutics University of British Columbia Associate Head, Centre of Heart
More informationLIMITE EN COUNCIL OF THE EUROPEAN UNION. Brussels, 7 July /11 LIMITE ENFOPOL 228 DAPIX 81
COUNCIL OF THE EUROPEAN UNION Brussels, 7 July 2011 12390/11 LIMITE ENFOPOL 228 DAPIX 81 NOTE From: Presidency To: Law Enforcement Working Party No. prev. doc.: CM 1508/11 Subject: Results of the questionnaire
More informationTrends in injecting drug use in Europe
Trends in injecting drug use in Europe Linda Montanari, Bruno Guarita and Danica Thanki Annual Expert Meeting on Drug-Related Infectious Diseases Lisbon, 15-17 October Overview of the presentation 1) Information
More informationYou Can Observe a Lot By Just Watching. Wayne J. Morgan, MD, CM
You Can Observe a Lot By Just Watching Wayne J. Morgan, MD, CM Disclosures Genentech Epidemiological Study of Cystic Fibrosis, Scientific Advisory Group CF Foundation Data Safety Monitoring Board Registry/Comparative
More informationCystic Fibrosis Foundation Patient Registry 2013
5/9/2015 Targeting CFTR to Treat Cystic Fibrosis: Small Molecule Therapy Mary Ellen Kleinhenz, MD Director, UCSF Adult Cystic Fibrosis Program Professor of Medicine UCSF Division of Pulmonary, Critical
More informationScreening programmes for Hepatitis B/C in Europe
Programme STI, HIV/AIDS and viral hepatitis Screening programmes for Hepatitis B/C in Europe Mika Salminen, Ph.D. European Centre for Disease Prevention and Control Why might screening be needed for hepatitis
More informationFinnish international trade 2017 Figures and diagrams. Finnish Customs Statistics
Finnish international trade 217 Figures and diagrams Finnish Customs Statistics IMPORTS, EXPORTS AND TRADE BALANCE 199-217 Billion e 7 6 5 4 3 2 1-1 9 91 92 93 94 95 96 97 98 99 1 2 3 4 5 6 7 8 9 1 11
More informationFinnish international trade 2017 Figures and diagrams. Finnish Customs Statistics
Finnish international trade 217 Figures and diagrams Finnish Customs Statistics IMPORTS, EXPORTS AND TRADE BALANCE 199-217 Billion e 7 6 5 4 3 2 1-1 9 91 92 93 94 95 96 97 98 99 1 2 3 4 5 6 7 8 9 1 11
More informationwater flows over gills What is meant by the term gas exchange? (1) Suggest three ways in which fish gills are adapted for efficient gas exchange.
1 Fish breathe by opening their mouths to allow water containing oxygen to pass over their gills. This is shown in the diagram. water flows in through mouth gill (a) (i) Gas exchange takes place in the
More informationImplementation Report on the patient safety Recommendation 2009/C 151/01. Healthcare Systems Unit DG SANCO
Implementation Report on the patient safety Recommendation 2009/C 151/01 Healthcare Systems Unit DG SANCO Published 15 November 2012 REPORT FROM THE COMMISSION TO THE COUNCIL on the basis of Member States'
More informationLab Activity Report: Mendelian Genetics - Genetic Disorders
Name Date Period Lab Activity Report: Mendelian Genetics - Genetic Disorders Background: Sometimes genetic disorders are caused by mutations to normal genes. When the mutation has been in the population
More informationCaregiver burden and quality of life of parents of young children with cystic fibrosis
Caregiver burden and quality of life of parents of young children with cystic fibrosis Professor Patricia Fitzpatrick 1 S George 1, R Somerville 1, B Linnane 2, C Fitzgerald 1 1 UCD School of Public Health,
More informationClinical Commissioning Policy: Levofloxacin nebuliser solution for chronic Pseudomonas lung infection in cystic fibrosis (all ages)
Clinical Commissioning Policy: Levofloxacin nebuliser solution for chronic Pseudomonas lung infection in cystic fibrosis (all ages) NHS England Reference: 1732P NHS England INFORMATION READER BOX Directorate
More informationReview of Member State approaches to the Macrophyte and Phytobenthos Biological Quality Element in lakes
Review of Member State approaches to the Macrophyte and Phytobenthos Biological Quality Element in lakes Report to ECOSTAT Martyn Kelly (Bowburn Consultancy, UK) Sebastian Birk (University of Duisburg-Essen,
More informationChanges in the management of children with Cystic Fibrosis. Caroline Murphy & Deirdre O Donovan CF Nurses
Changes in the management of children with Cystic Fibrosis Caroline Murphy & Deirdre O Donovan CF Nurses What Is Cystic Fibrosis? Cystic fibrosis (CF) is an inherited chronic disease that primarily affects
More informationPATIENT EDUCATION. Cystic Fibrosis Carrier Testing
PATIENT EDUCATION Cystic Fibrosis Carrier Testing Introduction Cystic fibrosis carrier testing before or during pregnancy can help determine your risk of having a child with cystic fibrosis. This information
More informationUK Cystic Fibrosis Registry
UK Cystic Fibrosis Registry 2015 Annual Data Report UK Cystic Fibrosis Registry 2015 Annual Data Report An at-a-glance version of this report can be found at www.cysticfibrosis.org.uk/registryreports
More informationCystic Fibrosis Carrier Testing
PATIENT EDUCATION Cystic Fibrosis Carrier Testing Introduction Cystic fibrosis carrier testing before or during pregnancy can help determine your risk of having a child with cystic fibrosis. This information
More information"Management and Treatment of Patients with Cystic fibrosis (CF)
"Management and Treatment of Patients with Cystic fibrosis (CF) Dr. Malena Cohen-Cymberknoh Pediatric Pulmonology and CF Center Hadassah Hebrew-University Medical Center Jerusalem, Israel Afula, March
More informationThe Future of CF Therapy
The Future of CF Therapy Peter J. Mogayzel, Jr., M.D., Ph.D. Eudowood Division of Pediatric Respiratory Sciences The Johns Hopkins School of Medicine Overview The Future of CF Therapy Personalized therapy
More informationTEST INFORMATION Test: CarrierMap GEN (Genotyping) Panel: CarrierMap Expanded Diseases Tested: 311 Genes Tested: 299 Mutations Tested: 2647
Ordering Practice Jane Smith John Smith Practice Code: 675 Miller MD 374 Broadway New York, NY 10000 Physician: Dr. Frank Miller Report Generated: 2016-02-03 DOB: 1973-02-19 Gender: Female Ethnicity: European
More informationB1 Question 1 Foundation
B1 Question 1 Foundation The nucleus controls the activities of a cell. The instructions for how an organism develops i.e. the genes are found in the nuclei of its cells B1 Question 2 Foundation The genes
More informationTHE ROLE OF CFTR MUTATIONS IN CAUSING CYSTIC FIBROSIS (CF)
THE ROLE OF CFTR MUTATIONS IN CAUSING CYSTIC FIBROSIS (CF) Vertex Pharmaceuticals Incorporated, 50 Northern Avenue, Boston, MA 02210. Vertex and the Vertex triangle logo are registered trademarks for Vertex
More informationVARIATIONS : IMPACT ON ADMINISTRATIVE BURDEN AND FEES. Rose-Marie Molina EMA Infoday London, 14th March 2014
Rose-Marie Molina EMA Infoday London, 14th March 2014 Before 1234/2008 Regulation, variation procedures in the European Union for industry was synonymous of: - Lack of visibility about timelines - Lack
More informationUK Cystic Fibrosis Registry
UK Cystic Fibrosis Registry Annual Data Report 2017 Scotland UK Cystic Fibrosis Registry 2017 Annual Data Report - Scotland Report prepared by Andrew Lee Statistician Cystic Fibrosis Trust Susan Charman
More informationCystic Fibrosis. Presented by: Chris Belanger & Dylan Medd
Cystic Fibrosis Presented by: Chris Belanger & Dylan Medd Outline What is Cystic Fibrosis? Signs, Symptoms & Diagnosis Who does it effect? General effects on daily life Managing Cystic Fibrosis Exercise
More informationUNDERSTANDING CYSTIC FIBROSIS
UNDERSTANDING CYSTIC FIBROSIS INTRODUCTION Cystic fibrosis is a chronic disease that affects the respiratory and gastrointestinal systems. People with cystic fibrosis have a genetic defect of the lungs
More informationSpreading Excellence and Widening Participation
Spreading Excellence and Widening Participation Dr G Ambroziewicz Ankara, 27/02/2017 Research and Background Disparities in research and innovation performance: barrier to competitiveness, growth and jobs
More informationMedical Policy An independent licensee of the Blue Cross Blue Shield Association
Cystic Fibrosis Transmembrane Page 1 of 13 Medical Policy An independent licensee of the Blue Cross Blue Shield Association Title: Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Prime Therapeutics
More informationWorking Group on Population Statistics
EUROPEAN COMMISSION EUROSTAT Directorate F: Social statistics Unit F-2: Population and migration Luxembourg, 13 October 2017 ESTAT/F2/POP/2017/WG1/03/SAR/GSB Working Group on Population Statistics Luxembourg,
More informationSeasonal influenza vaccination Recommendations & Reality
Seasonal influenza vaccination Recommendations & Reality World Vaccine Congress, 16-18 October 2012, Lyon, France Caroline Brown Influenza and other Respiratory Pathogens WHO Regional Office for Europe
More informationUK Cystic Fibrosis Registry. Annual Data Report 2017
UK Cystic Fibrosis Registry Annual Data Report 2017 Published August 2018 UK Cystic Fibrosis Registry 2017 Annual Data Report An at-a-glance version of this report can be found at cysticfibrosis.org.uk/registryreports
More informationPA Update: Oral Cystic Fibrosis Modulators
Copyright 2012 Oregon State University. All Rights Reserved Drug Use Research & Management Program Oregon State University, 500 Summer Street NE, E35 Salem, Oregon 97301-1079 Phone 503-947-5220 Fax 503-947-1119
More informationEIIW Competitiveness Report on the EU Market
EIIW Competitiveness Report on the EU Market Jens K. Perret Wuppertal, January 215 Preliminary European Institute for International Economic Relations at the University of Wuppertal, Rainer-Gruenter-Str.
More informationDutch Cystic Fibrosis Registry
Dutch Cystic Fibrosis Registry Annual report for 2017 1 Copyright NCFS 2018 The information from this report can be used for publications and presentations, but only with a reference to the source: Dutch
More informationWhat is Cystic Fibrosis? CYSTIC FIBROSIS. Genetics of CF
What is Cystic Fibrosis? CYSTIC FIBROSIS Lynne M. Quittell, M.D. Director, CF Center Columbia University Chronic, progressive and life limiting autosomal recessive genetic disease characterized by chronic
More informationEach person has a unique set of characteristics, such as eye colour, height and blood group.
1 of 51 2 of 51 What is inheritance? 3 of 51 Each person has a unique set of characteristics, such as eye colour, height and blood group. A person s characteristics are determined by a combination of the
More informationEfficacy of NaCl nebulized hypertonic solutions in cystic fibrosis
Acta Biomed 2014; Vol. 85, Supplement 4: 10-18 Mattioli 1885 Original article Efficacy of NaCl nebulized hypertonic solutions in cystic fibrosis Azienda Ospedaliero Universitaria Policlinico, DAI Scienze
More informationDutch Cystic Fibrosis Registry
Dutch Cystic Fibrosis Registry Report 2014 NCFS October, 2014 Copyright NCFS 2015 Data from this report may be used for publications and presentations provided the source of information is clearly identified
More informationCystic Fibrosis: Progress in Treatment Management. Patrick A. Flume, M.D. Medical University of South Carolina
Cystic Fibrosis: Progress in Treatment Management Patrick A. Flume, M.D. Medical University of South Carolina Disclosures Grant support Mpex Pharmaceuticals, Inc Gilead Sciences, Inc Bayer Healthcare AG
More informationTwo copies of each autosomal gene affect phenotype.
UNIT 3 GENETICS LESSON #34: Chromosomes and Phenotype Objective: Explain how the chromosomes on which genes are located can affect the expression of traits. Take a moment to look at the variety of treats
More informationNew trends in harm reduction in Europe: progress made challenges ahead
New trends in harm reduction in Europe: progress made challenges ahead Dagmar Hedrich, Alessandro Pirona, EMCDDA 2 nd European Harm Reduction Conference, 7-9 May 2014, Basel Session 4: Changes in harm
More informationUK Cystic Fibrosis Registry
UK Cystic Fibrosis Registry 2016 Annual Data Report Scotland UK Cystic Fibrosis Registry 2016 Annual Data Report An at-a-glance version of this report can be found at www.cysticfibrosis.org.uk/registryreports
More informationEUROPEAN MEDICINES AGENCY DECISION. of 20 July 2008
European Medicines Agency Doc. Ref. EMEA/357907/2008 P/53/2008 EUROPEAN MEDICINES AGENCY DECISION of 20 July 2008 on the application for agreement of a Paediatric Investigation Plan for Atorvastatin calcium
More informationAnswer Acceptable answers Mark. Answer Acceptable answers Mark. Answer Acceptable answers Mark. accept: 3 : 1. Answer Acceptable answers Mark
1a(i) answers must be in this order. dominant HH 1a(ii) 1a(iii) H h H HH Hh h Hh hh 1 mark for correct gametes 1 mark for correct offspring If incorrect gametes allow 1 mark for correct Punnett square
More informationPharmaceutical Pricing & Reimbursement Information. PPRI Project Co-ordination Sabine Vogler, Gesundheit Österreich GmbH
PPRI - Comparative Analysis PPRI Project Co-ordination Sabine Vogler, Gesundheit Österreich GmbH PPRI Conference Vienna, 29 June 2007 PPRI Conference, Vienna, 29 June 2007 1 Comparative Analysis - Outline
More informationMedical Physicists Improving treatments, saving lives
Medical Physicists Improving treatments, saving lives EFOMP presentation to the ICARO- 2 Conference The Role of professional societies and international organizations Dr. Stefano Gianolini Council Delegate
More informationResults of the Survey addressed to the EU Member States about quantification of food waste and preventing Food waste Brussels,
Results of the Survey addressed to the EU Member States about quantification of food waste and preventing Food waste Brussels, 29.11.2016 Survey Number of addressed countries: 29 28 (EU Member States)
More informationUK Cystic Fibrosis Registry 2014 Annual Data Report
UK Cystic Fibrosis Registry 2014 Annual Data Report Published August 2015 The content of this report may not be used or reproduced in publications without permission of the Cystic Fibrosis Trust. Contents
More informationDisclosures. Advances in the Management of Cystic Fibrosis: A Closer Look at the Roles of CFTR Modulation Therapy 10/28/2016
Advances in the Management of Cystic Fibrosis: A Closer Look at the Roles of CFTR Modulation Therapy Susanna A McColley, MD Associate Chief Research Officer Stanley Manne Children s Research Institute
More informationA Quick Guide to the. I507del. Mutation CFTR SCIENCE
A Quick Guide to the I507del Mutation CFTR SCIENCE 2016 Vertex Pharmaceuticals Incorporated VXR-HQ-02-00045a(1) 03/2016 Loss of CFTR activity is the underlying cause of cystic fibrosis (CF) 1 Spectrum
More informationUpdate on EEA s near real time air quality data exchange
Update on EEA s near real time air quality data exchange Jaume Targa (EEA ETC/ACC) Acknowledgement Thanks to all nrt data providers Currently there are 71 providers Latvian Environment, Geology and Name
More informationCalypso Application. License for card and portable objects.
Calypso Application License for card and portable objects. I N N O V A T R O N CalypsoLicense page 1 / 6 Innovatron, 27 rue de Bassano, 75008 Paris, France 1. License Policy General Presentation Innovatron
More informationEU Market Situation for Poultry. Committee for the Common Organisation of the Agricultural Markets 20 April 2017
EU Market Situation for Poultry Committee for the Common Organisation of the Agricultural Markets 2 April 217 -9.% -11.% -5.% -.1% -.7% -2.2% 3.% 1.7% 1.2%.8%.6%.%.%.% 7.9% 7.% 6.4% 6.2% 6.% 5.5% 5.3%
More informationHuman Genetic Diseases. AP Biology
Human Genetic Diseases 1 2 2006-2007 3 4 5 6 Pedigree analysis Pedigree analysis reveals Mendelian patterns in human inheritance data mapped on a family tree = male = female = male w/ trait = female w/
More informationExtrapolation and potential impact of IPHS deployment in Europe
SIMPHS2 Validation Workshop Brussels, 31 Jan 2012 1 SIMPHS2 Validation Workshop Extrapolation and potential impact of IPHS deployment in Europe JRC IPTS IS Unit Ioannis Maghiros, Fabienne Abadie, Maria
More informationAlcohol-related harm in Europe Key data
MEMO/06/397 Brussels, 24 October 2006 Alcohol-related harm in Europe Key data Alcohol-related harm in the EU: 55 million adults are estimated to drink at harmful levels in the EU (more than 40g of alcohol
More informationPORT CFNZ National Data Registry ~ 1 ~
PORT CFNZ 2014 National Data Registry ~ 1 ~ ~ 2 ~ The Port CFNZ National Data Registry is a research project of Cystic Fibrosis New Zealand. For further information about the CFNZ visit www.cfnz.org.nz
More informationPorta Potti Qube Campa Potti Qube User Manual
Porta Potti Qube Campa Potti Qube User Manual QUICK GUIDE Preparing waste-holding tank 1 2 3 QUICK GUIDE Emptying waste-holding tank 10 11 12 4 5 6 13 14 15 Preparing flush-water tank Emptying flush-water
More informationUK Cystic Fibrosis Registry Annual Data Report
UK Cystic Fibrosis Registry 2015 Annual Data Report Published August 2016 UK Cystic Fibrosis Registry 2015 Annual Data Report An at-a-glance version of this report can be found at www.cysticfibrosis.org.uk/registryreports
More informationConsequence of the change in the definition of. an agricultural parcel
Ispra, 03-04 April 2008 Kick-off Meeting of the 2008 CwRS Campaign 1 Consequence of the change in the definition of Andrew ROWLANDS MARS-PAC, JRC Ispra an agricultural parcel Ispra, 03-04 April 2008 Kick-off
More informationCh 8 Practice Questions
Ch 8 Practice Questions Multiple Choice Identify the choice that best completes the statement or answers the question. 1. What fraction of offspring of the cross Aa Aa is homozygous for the dominant allele?
More informationTuesday 15 May 2012 Morning Time: 1 hour plus your additional time allowance
Paper Reference(s) 5BI1H/01 Edexcel GCSE Biology/Science Unit B1: Influences on Life Higher Tier Tuesday 15 May 2012 Morning Time: 1 hour plus your additional time allowance INSTRUCTIONS TO CANDIDATES
More informationHuman Genetic Diseases (Ch. 15)
Human Genetic Diseases (Ch. 15) 1 2 2006-2007 3 4 5 6 Genetic counseling Pedigrees can help us understand the past & predict the future Thousands of genetic disorders are inherited as simple recessive
More informationFresh fruit and vegetable production, trade, supply & consumption monitor in the EU-27 (covering ) With the support of:
Fresh fruit and vegetable production, trade, supply & consumption monitor in the EU-27 (covering 2005-2010) With the support of: Freshfel Fruit and Vegetable Production, Trade, Supply & Consumption Monitor
More informationCYSTIC FIBROSIS FOUNDATION INFO-POD Information You Need to Make Benefits Decisions
CYSTIC FIBROSIS FOUNDATION INFO-POD Information You Need to Make Benefits Decisions Issue 1: Hypertonic Saline Summary: Preserving lung function is a crucial element in the care of the individual with
More informationMedical Policy An independent licensee of the Blue Cross Blue Shield Association
Cystic Fibrosis Transmembrane Page 1 of 11 Medical Policy An independent licensee of the Blue Cross Blue Shield Association Title: Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Prime Therapeutics
More informationFemale genital mutilation: estimating girls at risk. Jurgita Peciuriene
Female genital mutilation: estimating girls at risk Jurgita Peciuriene EU framework Resolution 2012 on ending FGM Resolution 2014 on the Commission communication Towards the elimination of FGM Web-platform
More informationHow to get involved in Cystic Fibrosis Research
How to get involved in Cystic Fibrosis Research Information for patients and the public www.uhsm.nhs.uk/cysticfibrosis www.facebook.com/macfc.uhsm CONTENTS 4 GENERAL INFORMATION 4 Who is this booklet
More informationEUROPEAN COMMISSION DIRECTORATE GENERAL FOR HEALTH AND FOOD SAFETY
Ref. Ares(2016)5909621-13/10/2016 EUROPEAN COMMISSION DIRECTORATE GENERAL FOR HEALTH AND FOOD SAFETY Directorate B - Health systems, medical products and innovation B4 Medical products: quality, safety
More informationItem 2.2 Household definition
EUROPEAN COMMISSION EUROSTAT Directorate F: Social statistics Doc. DSSB/2016/Jun/2.2 Item 2.2 Household definition MEETING OF THE BOARD OF THE EUROPEAN DIRECTORS OF SOCIAL STATISTICS LUXEMBOURG, 28 AND
More informationCYSTIC FIBROSIS REGISTRY
THE CANADIAN CYSTIC FIBROSIS REGISTRY 16 ANNUAL DATA REPORT Canadian Cystic Fibrosis Registry 16 Annual Data Report 1 CYSTIC FIBROSIS Cystic fibrosis (CF) is a rare disease affecting over 4, Canadians
More informationMonitoring misuse of psychoactive medicines at the EMCDDA
Monitoring misuse of psychoactive medicines at the EMCDDA Indicator prevalence and patterns of drug use among general population EMCDDA Annual Expert meeting 17-18 June 2014 2 Background Mandate The EMCDDA
More informationB1 You and Your Genes Q3 Question: What are alleles?
Q1 : Where are chromosomes found within a cell? Inside the nucleus. Q2 : Put the following in size order starting with the smallest first: nucleus, chromosome, cell, gene. Gene, chromosome, nucleus, cell.
More informationInequality and Happiness
Inequality and Happiness Claudia Biancotti and Giovanni D Alessio Bank of Italy, Economic Research Department Unequal results Theoretical work, field experiments and surveybased studies show that inequality
More informationState of play of Leader/CLLD preliminary analysis
State of play of Leader/CLLD preliminary analysis #LeaderCLLD Urszula Budzich-Tabor, ENRD CP Brussels, 23 June 2015 DG AGRI analysis of draft RDPs Indicative allocation of budget for LEADER (total public):
More informationTEPZZ _7584 A_T EP A1 (19) (11) EP A1 (12) EUROPEAN PATENT APPLICATION. (51) Int Cl.: A61K 9/00 ( ) A61K 31/439 (2006.
(19) TEPZZ _784 A_T (11) EP 3 17 842 A1 (12) EUROPEAN PATENT APPLICATION (43) Date of publication: 07.06.17 Bulletin 17/23 (1) Int Cl.: A61K 9/00 (06.01) A61K 31/439 (06.01) (21) Application number: 1197874.9
More informationAttention. Therefore, all the data and statements made in this presentation are preliminary and might change in the future.
Attention The aim of the Dose Datamed II workshop in Athens was to present preliminary data, collect feedback from the audience and to work towards final results and conclusions. Therefore, all the data
More informationList of nationally authorised medicinal products
10 September 2015 EMA/677092/2015 Procedure Management and Committees Support Active substance: glatiramer Procedure no.: PSUSA/00001529/201411 30 Churchill Place Canary Wharf London E14 5EU United Kingdom
More informationE-BOOK # PANCREATIC ENZYMES FOR CYSTIC FIBROSIS ARCHIVE
10 June, 2018 E-BOOK # PANCREATIC ENZYMES FOR CYSTIC FIBROSIS ARCHIVE Document Filetype: PDF 220.67 KB 0 E-BOOK # PANCREATIC ENZYMES FOR CYSTIC FIBROSIS ARCHIVE If you have a systemic illness like lupus
More informationScheduler API (TIMETABLE_PLUGIN)
Page 1 of 18 Scheduler API (TIMETABLE_PLUGIN) V 1.6 2018-03-06 Page 2 of 18 Table of Contents Document history 3 Foreword 4 Scheduler API (TIMETABLE_PLUGIN) introduction 5 HTTP Request Definitions 6 2.1
More informationWhat is the inheritance pattern (e.g., autosomal, sex-linked, dominant, recessive, etc.)?
Module I: Introduction to the disease Give a brief introduction to the disease, considering the following: the symptoms that define the syndrome, the range of phenotypes exhibited by individuals with the
More informationKey Points: References: Canadian data from the Canadian Cystic Fibrosis Registry 2015 Annual Report normal
1 2 3 Cystic fibrosis is a rare life-long genetic disease that affects approximately 4,000 people in Canada and about 70,000 worldwide regardless of race or ethnicity but is more common in Caucasians 1,2
More informationANNUAL REPORT on surveillance for avian influenza in poultry in the EU in 2009
EUROPEAN COMMISSION ANNUAL REPORT on surveillance for avian influenza in poultry in the EU in 2009 Prepared by the European Union Reference Laboratory for Avian Influenza Neither the European Commission
More information31 countries (117 registries, 20 national) Increased coverage in countries with regional registries 50% European population Overall >20 million
31 countries (117 registries, 20 national) Increased coverage in countries with regional registries 50% European population Overall >20 million cancer cases Adult patients (age 15+) 45 major cancer sites
More informationDutch Cystic Fibrosis Registy
Dutch Cystic Fibrosis Registy Report 2016 NCFS October 2017 Copyright NCFS 2017 The information from this report can be used for publications and presentations, but only with a reference to the source:
More informationYoung people and drugs. Analytical report
Flash Eurobarometer European Commission Young people and drugs among 15-24 year-olds Analytical report Fieldwork: May 2008 Report: May 2008 Flash Eurobarometer 233 The Gallup Organization This survey was
More informationThe European Commission s science and knowledge service Smart Baltic
The European Commission s science and knowledge service Joint Research Centre S3P ENERGY WORKSHOP Smart Baltic Smart grid challenges and opportunities in the Baltic region flaviagangale@ec.europa.eu JRC
More informationFriday, January 4. Bell Work:
Friday, January 4 Bell Work: Red green colorblindness is an X linked trait and is recessive. A male who is normal marries a woman who is a carrier, what is the phenotypic ratio of their offspring? 1 Genetic
More informationFieldwork: February March 2010 Publication: October 2010
Special Eurobarometer 345 European Commission Mental Health Part 1: Report Fieldwork: February March 2010 Publication: October 2010 Special Eurobarometer 345 / Wave 73.2 TNS Opinion & Social This survey
More information(43) Publication date: 04 September 2014 ( ) (22) Filing Date: 27 February 2014 ( )
(54) Title (EN): INCOHERENT TYPE-III MATERIALS FOR CHARGE CARRIERS CONTROL DEVICES (54) Title (FR): MATÉRIAUX DE TYPE III INCOHÉRENTS POUR DISPOSITIFS DE RÉGULATION DE PORTEURS DE CHARGES (72) Inventor(s):
More information